Cite
HARVARD Citation
Biemans, V. et al. (n.d.). P587 Drug survival of vedolizumab-treated inflammatory bowel disease patients in a nationwide observational cohort study: ICC case series. Journal of Crohn's and colitis. pp. S404-S405. [Online].